NATALIE JONES-BROWN: Open Payments
NPI 1972056406 · FERNDALE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,278 in 85 payments from 15 companies in 2025. Trend: 2023 $399 · 2024 $1,594 · 2025 $2,278
Food & beverage: $2,147Education: $111Travel & lodging: $20
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $489 |
| Axsome Therapeutics, Inc. | 14 | $484 |
| ABBVIE INC. | 16 | $284 |
| Supernus Pharmaceuticals, Inc. | 4 | $179 |
| Lundbeck LLC | 8 | $168 |
| Otsuka America Pharmaceutical, Inc. | 7 | $162 |
| Teva Pharmaceuticals USA, Inc. | 4 | $159 |
| Janssen Pharmaceuticals, Inc | 3 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Alkermes, Inc. | 3 | $67 |
Products named: INGREZZA, Auvelity, REXULTI, VRAYLAR, Qelbree, SPRAVATO, TRINTELLIX, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
